green
Positive treatment
published
Quoted verbatim 1×
14.0 score
Treatment trajectory · 1999 → 2026 · click a year to view as-of
1999
2012
2026
Cited for
Other citing cases
- Vanz, LLC v. PMD Fin. Grp., LLC, 2019 DNH 058 (D.N.H. 2019).published
- United States v. Kyle Wagner, No. 26-1294 (6th Cir. Aug. 12, 2026).published
- Falk v. Sinclair, 692 F. Supp. 2d 147 (D. Me. 2010).published
- McManus v. McManus, 354 F. Supp. 2d 62 (D. Mass. 2005).published
- Bocquet v. Ouzid, 225 F. Supp. 2d 1337 (S.D. Fla. 2002).published
- United States v. Paquette, 201 F.3d 40 (1st Cir. 2000).published
- United States v. Mark E. Huddleston, 194 F.3d 214 (1st Cir. 1999).published
United States
v.
Dure
v.
Dure
98-1686.
Court of Appeals for the First Circuit.
Feb 12, 1999.
Published opinion
181 F.3d 81
Cited by 18 opinions | Published
Citer courts: D. New Hampshire (1)
[*~81–82]
Per Curiam.
Upon careful review of the briefs and record, we conclude that the district court did not clearly err in denying defendant's request for an adjustment under U.S.S.G. § 3B1.2 (mitigating role in offense). On the facts before it, the district court reasonably concluded that the drug trafficking offense was a "joint venture" that "would not have occurred without [defendant's] participation." Even though defendant may have been less culpable than his joint venture partner, still defendant was not "less culpable than the average participant" in similar drug trafficking conspiracies, [*2] and so he was not entitled to any adjustment. See United States v. Brandon, 17 F.3d 409, 460 (1st Cir. 1994).
Affirmed. See 1st Cir. Loc. R. 27.1.